Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
- 1.1 TOTAL ORTHOPEDIC BIOMATERIAL MARKET
- 1.2 GROWTH FACTOR AND BONE GRAFT SUBSTITUTE MARKET
- 1.3 MACHINED ALLOGRAFT MARKET
- 1.4 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- 1.5 RESORBABLE FIXATION MARKET
- 1.6 TENDON GRAFT MARKET
- 1.7 CARTILAGE REPAIR MARKET
- 1.8 PLATELET / BONE MARROW CONCENTRATION MARKET
- 1.9 STEM CELL MARKET
- 1.1O LEADING COMPETITORS
RESEARCH METHODOLOGY
- 2.1 RESEARCH SCOPE
- 2.2 IDATA' S 9-STEP METHODOLOGY
- 2.2.1 Step 1: Project initiation & Team Selection
- 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
- 2.2.3 Step 3: Preparation for Interviews & Survey Design
- 2.2.4 Step 4: Performing Primary Research
- 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
- 2.2.6 Step 6: Market Forecasting
- 2.2.7 Step 7: Identify Strategic Opportunities
- 2.2.8 Step 8: Final Review and Market Release
- 2.2.9 Step 9: Customer Feedback and Market Monitoring
OVERVIEW OF ORTHOPEDIC BIOMATERIALS
- 3.1 INTRODUCTION
- 3.2 OVERVIEW
- 3.2.1 Growth Factors
- 3.2.2 Bone Graft Substitute
- 3.2.3 Machined Bone Allografts
- 3.2.4 Hyaluronic Acid Viscosupplementation
- 3.2.5 Resorbable Tissue and Bone Fixation devices
- 3.2.6 Tendon Allografts
- 3.2.7 Cartilage Repair
- 3.2.8 Platelet and Bone Marrow Concentration
- 3.2.9 Stem Cell Therapy
- 3.3 MARKET FORECAST AND ANALYSIS
- 3.4 MARKET DRIVERS AND LIMITERS
- 3.4.1 Market Drivers
- 3.4.2 Market Limiters
- 3.5 COMPETITIVE ANALYSIS
- 3.5.I Market Share
- 3.5.2 Market Concentration
- 3.6 MERGERS AND ACQUISITIONS
GROWTH FACTOR MARKET
- 4.1 INTRODUCTION
- 4.1.1 Overview
- 4.1.2 BMP-2 (Medtronic)
- 4.1.3 BMP-7 (Stryker)
- 4.1.4 Potential Complications
- 4.1.5 Future indications
- 4.2 MARKET FORECAST AND ANALYSIS
- 4.2.1 Total Growth Factor Market
- 4.3 MARKET DRIVERS AND LIMITERS
- 4.3.1 Market Drivers
- 4.3.2 Market Limiters
- 4.4 COMPETITIVE ANALYSIS
BONE GRAFT SUBSTITUTE MARKET
- 5.1 INTRODUCTION
- 5.2 OVERVIEW
- 5.2.1 Thoracolumber Fixation Procedure Forecast
- 5.2.2 Autograft Procedure Forecast
- 5.2.3 Non-Proprietary Allograft
- 5.2.4 Demineralized Bone Matrix (DMB)
- 5.2.5 Synthetic
- 5.2.6 Xenografts
- 5.3 MARKET FORECAST AND ANALYSIS
- 5.3.1 Total Bone Graft Substitute Market
- 5.3.2 Thoracolumbar Bone Graft Substitute Market
- 5.3.3 Cervical Bone Graft Substitute Market
- 5.3.4 Trauma Bone Graft Substitute Market
- 5.3.5 Hip Bone Graft Substitute Market
- 5.3.6 Knee Bone Graft Substitute Market
- 5.3.7 Craniomaxillofacial Bone Graft Substitute Market
- 5.3.8 Total Standard Allograft
- 5.3.9 Spinal Standard Allograft Market
- 5.3.10 Spinal Standard Allograft Market, Thoracolumbar
- 5.3.11 Spinal Standard Allograft Market, Cervical
- 5.3.12 Trauma, Reconstruction and Craniomaxillofacial Standard Allograft Markets
- 5.3.13 Total DMB Market
- 5.3.14 Spinal DBM Market
- 5.3.15 Spinal DBM Market, Thoracolumbar
- 5.3.16 Spinal DBM Market, Cervical
- 5.3.17 Trauma, Reconstruction and Craniomaxillofacial DBM Markets
- 5.3.18 Total Synthetic Bone Graft Substitute Market
- 5.3.19 Spinal Synthetic Bone Graft Substitute Market
- 5.3.20 Spinal Synthetic Bone Graft Substitute Market, Thoracolumbar
- 5.3.21 Spinal Synthetic Bone Graft Market, Cervical
- 5.3.22 Trauma, Reconstruction and Craniomaxillofacial Synthetic Bone Graft Substitute Markets
- 5.4 MARKET DRIVERS AND LIMITERS
- 5.4.1 Allograft Market Drivers
- 5.4.2 Standard Allograft Market Limiters
- 5.4.3 DBM Market Drivers
- 5.4.4 DBM Market Limiters
- 5.4.5 Synthetic Market Drivers
- 5.4.6 Synthetic Market Limiters
- 5.5 COMPETITIVE ANALYSIS
- 5.5.1 Total Bone Graft Substitute Market
- 5.5.2 Standard Allografts
- 5.5.3 DBM
- 5.5.4 Synthetic Bone Graft Substitutes
- 5.5.5 Autografts
MACHINED BONE ALLOGRAFT MARKET
- 6.1 INTRODUCTION
- 6.2 OVERVIEW
- 6.2.1 Approaches
- 6.2.2 interbody Device Procedure Percentages by Material
- 6.3 MARKET FORECAST AND ANALYSIS
- 6.3.1 Total Machined Bone Allograft Market
- 6.3.2 ALIF Approach
- 6.3.3 PLIF Approach
- 6.3.4 TLIF Approach
- 6.3.5 Cervical Machined Bone Allografts
- 6.4 MARKET DRIVERS AND LIMITERS
- 6.4.1 Market Drivers
- 6.4.2 Market Limiters Drivers
- 6.5 COMPETITIVE ANALYSIS
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- 7.1 INTRODUCTION
- 7.2 OVERVIEW
- 7.2.1 Three-Injection Cycle Products
- 7.2.2 Five-Injection Cycle Products
- 7.2.3 Single-Injection Cycle Products
- 7.2.4 Reimbursement
- 7.3 MARKET FORECAST AND ANALYSIS
- 7.3.1 Total Viscosupplementation Market
- 7.3.2 Three-Injection Cycle
- 7.3.3 Five-Injection Cycle
- 7.4 MARKET DRIVERS AND LIMITERS
- 7.4.1 Market Drivers
- 7.4.2 Market Limiters
- 7.5 COMPETITIVE ANALYSIS
RESORBABLE FIXATION DEVICES
- 8.1 INTRODUCTION
- 8.1.1 ACL/PCL Reconstruction Procedure Forecast
- 8.2 OVERVIEW
- 8.2.1 Materials
- 8.2.2 Disadvantages Compared to Metal Fixation
- 8.2.3 Product Description
- 8.3 MARKET FORECAST AND ANALYSIS
- 8.3.1 Total Resorbable Market
- 8.3.2 Resorbable Shoulder Fixation
- 8.3.3 Total ACL/PCL Resorbable Fixation Market
- 8.3.4 ACL/PCL Fixation, Total Interference Screws
- 8.3.5 ACL/PCL Fixation, Standard Resorbable interference Screws
- 8.3.6 ACL/PCL Fixation, Composite Resorbable Interference Screws
- 8.3.7 ACL/PCL Fixation, Resorbable Cross Pins
- 8.3.8 Total Resorbable Meniscal Market
- 8.3.9 Mensical Fixation, Meniscal Tacks
- 8.3.10 Meniscal Fixation, Hybrid Tacks
- 8.3.11 Resorbable Fracture Fixation Devices
- 8.4 MARKET DRIVERS AND LIMITERS
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
- 8.5 COMPETITIVE ANALYSIS
TENDON GRAFT MARKET
- 9.1 INTRODUCTION
- 9.1 ACL/PCL Reconstruction Procedures
- 9.2 OVERVIEW
- 9.2.1 Bone Patellar Tendon-Bone (BTB) Graft, ACL/PCL Surgery
- 9.2.2 Allograft Tendons
- 9.2.3 Popularity of the Anterior Tibialis Autograft
- 9.2.4 Ligament and Tendon Synthetic Grafts
- 9.2.5 Ligament and Tendon Xenografts
- 9.3 MARKET FORECAST AND ANALYSIS
- 9.3.1 Total Tendon Graft Market
- 9.3.2 Analysis of Tendon Units Procured per Donor
- 9.4 MARKET DRIVERS AND LIMITERS
- 9.4.1 Market Drivers
- 9.4.2 Market Limiters
- 9.5 COMPETITIVE ANALYSIS
CARTILAGE REPAIR MARKET
- 1O.1 INTRODUCTION
- 1O.2 OVERVIEW
- 10.2.1 Autograft
- 10.2.2 Cartilage Autograft Procedure Forecast
- 10.2.3 Autologous Chondrocyte Implantation
- 10.2.4 Osteoarticular Allografts
- l0.2.5 Meniscal Allografts
- 10.2.6 Emerging Technologies
- MARKET FORECAST AND ANALYSIS
- 10.2.7 Total Cartilage Repair Market
- 10.2.8 Autologous Chondrocyte Implantation
- 10.2.9 Cartilage Allografts, Osteochondral Allografts
- 10.2.10 Cartilage Allografts, Meniscal Grafts
- MARKET DRIVERS AND LIMITERS
- 10.2.11 Market Drivers
- 10.2.12 Market Limiters
- 1O.3 COMPETITIVE ANALYSIS
PLATELET AND BONE MARROW CONCENTRATION MARKET
- 11.1 INTRODUCTION
- 11.2 OVERVIEW
- 11.2.1 Platelet Rich Plasma
- ll.2.2 Bone Marrow Aspirate
- 11.3 MARKET FORECAST AND ANALYSIS
- 11.3.1 Total Platelet and Bone Marrow Concentration Market
- 11.3.2 Spinal Platelet Concentration
- 11.3.3 Extremity and Sports Medicine Platelet Concentration
- ll.3.4 Bone Marrow Aspirate Concentration
- 11.4 MARKET DRIVERS AND LIMITERS
- 11.4.1 Market Drivers
- 11.4.2 Market Limiters
- 11.5 COMPETITIVE ANALYSIS
ORTHOPEDIC STEM CELL MARKET
- 12.1 INTRODUCTION
- 12.2 OVERVIEW
- 12.2.1 Lineage
- 12.2.2 Legislation
- 12.2.3 0ther Therapeutic Applications
- 12.3 MARKET FORECAST AND ANALYSIS
- 12.3.1 0rthopedic Stem Cells
- 12.3.2 Analysis of Potential Stem Cell Market
- 12.4 MARKET DRIVERS AND LIMITERS
- 12.4.1 Market Drivers
- 12.4.2 Market Limiters
- 12.5 COMPETITIVE ANALYSIS
ABBREVIATIONS
LIST OF FIGURES
- EXECUTIVE SUMMARY
- RESEARCH METHODOLOGY
- OVERVIEW OF ORTHOPEDIC BIOMATERIALS
- Figure 3-1 Total Orthopedic Biomaterials Market, U.S., 2004-2014
- Figure 3-2 Drivers and Limiters, Orthopedic Biomaterials Market, U.S., 2007
- Figure 3-3 Leading Competitors, Orthopedic Biomaterials Market, U.S., 2007
(Part 1 of 2)
- Figure 3-4 Leading Competitors, Orthopedic Biomaterials Market, U.S., 2007
(Part 2 of 2)
- Figure 3-5 Market Concentration, Orthopedic Biomaterials Market, U.S., 2007
- GROWTH FACTOR MARKET
- Figure 4-1 Total Growth Factor Market, U.S., 2004-2014
- Figure 4-2 Market Drivers and Limiters, Growth Factor Market, U.S., 2007
- Figure 4-3 Leading Competitors, Growth Factor Market, U.S., 2007
- BONE GRAFT SUBSTITUTE MARKET
- Figure 5-1 Thoracolumbar Fixation Procedures Segmented by Indication,
U.S., 2004-2014
- Figure 5-2 Degenerative Thoracolumbar Fixation Procedures Segmented Levels
Fused U.S., 2004 2014
- Figure 5-3 Spinal Bone Graft Substitutes Procedure Forecast, U.S.,
2004-2014
- Figure 5-4 Total Bone Graft Substitute Market, U.S., 2004-2014
- Figure 5-5 Thoracolumbar Bone Graft Substitute Market, U.S., 2004-2014
- Figure 5-6 Cervical Bone Graft Substitute Market, U.S., 2004-2014
- Figure 5-7 Trauma Bone Graft Substitute Market, U.S., 2004-2014
- Figure 5-8 Hip Bone Graft Substitute Market, U.S., 2004-2014
- Figure 5-9 Knee Bone Graft Substitute Market, U.S., 2004-2014
- Figure 5-10 Craniomaxillofacial Bone Graft Substitute Market, U.S.,
2004-2014
- Figure 5-11 Total Standard Allograft Market, U.S., 2004-2014
- Figure 5-12 Spinal Standard Allograft Market, U.S., 2004-2014
- Figure 5-13 Thoracolumbar Standard Allograft Market, U.S., 2004-2014
- Figure 5-14 Cervical Standard Allograft Market, U.S., 2004-2014
- Figure 5-15 Extremity and Craniomaxillofacial Standard Allograft Market
U.S., 2004-2014
- Figure 5-16 Trauma Standard Allograft Market, U.S., 2004-2014
- Figure 5-17 Hip Reconstruction Standard Allograft Market, U.S., 2004-2014
- Figure 5-18 Knee Reconstruction Standard Allograft Market, U.S., 2004-2014
- Figure 5-19 Total DBM Market, U.S., 2004-2014
- Figure 5-20 Spinal DBM Market, U.S., 2004-2014
- Figure 5-21 Thoracolumbar DBM Market, U.S., 2004-2014
- Figure 5-22 Cervical DBM Market, U.S., 2004-2014
- Figure 5-23 Extremity and Craniomaxillofacial DBM Market, U.S., 2004-2014
- Figure 5-24 Trauma DBM Market, U.S., 2004-2014
- Figure 5-25 Hip Reconstruction DBM Market, U.S., 2004-2014
- Figure 5-26 Knee Reconstruction DBM Market, U.S., 2004-2014
- Figure 5-27 Total Synthetic Bone Graft Substitute Market, U.S., 2004-2014
- Figure 5-28 Spinal Synthetic Bone Graft Substitute Market, U.S., 2004-2014
- Figure 5-29 Thoracolumbar Synthetic Bone Graft Substitute Market, U.S.,
2004-2014
- Figure 5-30 Cervical Synthetic Bone Graft Market, U.S., 2004-2014
- Figure 5-31 Extremity and Craniomaxillofacial Synthetic Bone Graft
Substitute Market, U.S., 2004-2014
- Figure 5-32 Trauma Synthetic Bone Graft Substitute Market, U.S., 2004-2014
- Figure 5-33 Hip Reconstruction Synthetic Bone Graft Substitute Market,
U.S., 2004-2014
- Figure 5-34 Knee Reconstruction Synthetic Bone Graft Substitute Market,
U.S., 2004-2014
- Figure 5-35 Drivers and Limiters, Standard Allograft Market, U.S., 2007
- Figure 5-36 Drivers and Limiters, DBM Market, U.S., 2007
- Figure 5-37 Drivers and Limiters, Synthetic Bone Graft Substitute Market,
U.S., 2007
- Figure 5-38
- Figure 5-39 Leading Competitors, Bone Graft Substitute Market, U.S., 2007
- Figure 5-40 Leading Competitors, Standard Allograft Market, U.S., 2007
- Figure 5-41 Leading Competitors, DBM Market, U.S., 2007
- Figure 5-42 Leading Competitors, Synthetic Bone Graft Substitute Market
U.S., 2007
- MACHINED BONE ALLOGRAFT MARKET
- Figure 6-1 ALIF Interbody Device Percentages by Material, U.S., 2004-2014
- Figure 6-2 PLIF Interbody Device Percentages by Material, U.S., 2004-2014
- Figure 6-3 TLIF Interbody Device Percentages by Material, U.S., 2004-2014
- Figure 6-4 Cervical Interbody Device Percentages by Material, U.S.,
2004-2014
- Figure 6-5 Total Machined Allograft Market, U.S., 2004-2014
- Figure 6-6 ALIF, Percentage of Total Machined Bone Allograft Procedures
U.S., 2004-2014
- Figure 6-7 ALIF Machined Bone Allograft Market, U.S., 2004-2014
- Figure 6-8 PLIF, Percentage of Total Machined Bone Allograft Procedure
U.S., 2004-2014
- Figure 6-9 PLIF Machined Bone Allograft Market, U.S., 2004-2014
- Figure 6-10 TLIF, Percentage of Total Machined Bone Allograft Procedure
U.S., 2004-2014
- Figure 6-11 TLIF Machined Bone Allograft Market, U.S., 2004 2014
- Figure 6-12 Cervical, Percentage of Total Machined Bone Allograft
Procedure U.S., 2004-2014
- Figure 6-13 Cervical Machined Bone Allograft Market, U.S., 2004-2014
- Figure 6-14 Drivers and Limiters, Machined Bone Allograft Market, U.S.,
2007
- Figure 6-15 Leading Competitors, Machined Bone Allograft Market, U.S., 2007
- HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- Figure 7-1 Hyaluronic Acid Viscosupplementation J-Codes, 2007
- Figure 7-2 Hyaluronic Acid Viscosupplementation Market, U.S., 2004-2014
- Figure 7-3 Three-Injection Cycle Viscosupplementation Market, U.S.,
2004-2014
- Figure 7-4 Five-Injection Cycle Hyluronic Acid Viscosupplmentation Market,
U.S., 2004-2014
- Figure 7-5 Drivers and Limiters, Hyluronic Viscosupplmentation Market,
U.S., 2007
- Figure 7-6 Leading Competitors, Hyluronic Acid Viscosupplementation Market
U.S., 2007
- RESORBABLE FIXATION DEVICES
- Figure 8-1 ACL/PCL Reconstruction Procedures, U.S., 2004-2014
- Figure 8-2 Total Resorbable Fixation Device Market, U.S., 2004-2014
- Figure 8-3 Total Resorbable Fixation Device Market by Segment, U.S.,
2004-2014
- Figure 8-4 Resorbable Shoulder Fixation Market, U.S., 2004 2014
- Figure 8-5 Total ACL/PCL Resorbable Fixation Market, U.S., 2004-2014
- Figure 8-6 ACL/PCL Total Resorbable Interference Screw Market, U.S.,
2004-2014
- Figure 8-7 Resorbable Interference Screw Market by Material, U.S.,
2004-2014
- Figure 8-8 ACL/PCL Standard Resorbable Interference Screw Market, U.S.
2004-2014
- Figure 8-9 ACL/PCL Composite Resorbable Interference Screw Market, U.S.,
2004 2014
- Figure 8-10 ACL/PCL Resorbable Cross Pin Market, U.S., 2004 2014
- Figure 8-11 Total Resorbable Meniscal Fixation Market, U.S., 2004 2014
- Figure 8-12 Meniscal Tack Market, U.S., 2004 2014
- Figure 8-13 Hybrid Tack Market, U.S., 2004-2014
- Figure 8-14 Resorbable Fracture Fixation Market, U.S., 2004 2014
- Figure 8-15 Drivers and Limiters,Resorbable Fixation Market, U.S., 2007
- Figure 8-16 Leading Competitors, Total Resorbable Fixation Market, U.S.,
2007
- Figure 8-17 Leading Competitors, Resorbable Shoulder Fixation Market,
U.S., 2007
- Figure 8-18 Leading Competitors, Resorbable ACL/PCL Fixation Market, U.S.,
2007
- Figure 8-19 Leading Competitors, Resorbable Meniscus Fixation Market,
U.S., 2007
- Figure 8-20 Leading Competitors, Resorbable Fracture Fixation Market,
U.S., 2007
- TENDON GRAFT MARKET
- Figure 9-1 ACL/PCL Reconstruction Procedures, U.S., 2004 2014
- Figure 9-2 Total Tendon Graft Market, U.S., 2004 2014
- Figure 9-3 Units Procured per Donor, U.S., 2007
- Figure 9-4 Market Drivers and Limiters, Tendon Graft Market, U.S., 2007
- Figure 9-5 Leading Competitors, Tendon Graft Market, U.S., 2007
- CARTILAGE REPAIR MARKET
- Figure 10-1 Cartilage Autograft Procedures, U.S., 2004-2014
- Figure 1O-2 Total Cartilage Repair Market, U.S., 2004-2014
- Figure 10-3 ACI Market, U.S., 2004-2014
- Figure 1O-4 Osteochondral Allograft Market, U.S., 2004-2014
- Figure 10-5 Meniscal Graft Market, U.S., 2004-2014
- Figure 10-6 Drivers and Limiters, Cartilage Repair Market, U.S., 2007
- Figure 10-7 Leading Competitors, Cartilage Repair Market, U.S., 2007
- Figure 10-8 Leading Competitors, ACI Market, U.S., 2007
- Figure 10-9 Lea mg Competitors, Cartilage Allograft Market, U.S., 2007
- PLATELET AND BONE MARROW CONCENTRATION MARKET
- Figure 11-1 Total Platelet and Bone Marrow Concentration Market, U.S.,
2004 -2014
- Figure 11-2 Spinal Platelet Concentration Market, U.S., 2004-2104
- Figure 11-3 Extremity and Sports Medicine Platelet Concentration, U.S.,
2004 -2014
- Figure 11-4 Bone Marrow Aspirate Concentration Market, U.S., 2004-2104
- Figure 11-5 Drivers and Limiters, Platelet and Bone Marrow Concentration
Market, U.S., 2007
- Figure 11-6 Leading Competitors, Platelet and Bone Marrow Concentration
Market, 2007
- 0RTHOPEDIC STEM CELL MARKET
- Figure 12-1 Orthopedic Stem Cell Market, U.S., 2004-2014
- Figure 12-2 Potential Stem Cell Market, U.S., 2008-2014
- Figure 12-3 Drivers and Limiters, Orthopedic Stem Cell Market, U.S., 2007
ABBREVIATIONS
LIST OF CHARTS
- EXECUTIVE SUMMARY
- Chart 1-1 Total Orthopedic Biomaterials Market, U.S. 2007
- Chart 1-2 Growth Factor and Bone Graft Substitute Markets, U.S., 2004-2014
- Chart 1-3 Machined Bone Allograft Market, U.S., 2004-2014
- Chart 1-4 Resorbable Fixation Market, U.S., 2007
- Chart 1-5 Tendon Allograft Unit Volumes in Relation to ACL/PCL Procedures,
U.S. 2004-2014
- Chart 1-6 Cartilage Repair Market, U.S., 2004-2014
- Chart 1-7 Platelet Concentration Market Growth Rate, 2004-2007
- Chart 1-8 Potential Value of Future Stem Cell Market Entrants, Cumulative
Market Value, U.S. 2008-2014
- Chart 1-9 Leading Competitors, Orthopedic Biomaterials Market, U.S., 2007
- RESEARCH METHODOLOGY
- OVERVIEW OF ORTHOPEDIC BIOMATERIALS
- Chart 3-1 Total Orthopedic Biomaterials Market, U.S., 2004-2014
- Chart 3-2 Total Orthopedic Biomaterials Market by Segment, U.S., 2004-2014
- Chart 3-3 Total Orthopedic Biomaterials Market by Segment, U.S., 2007
- Chart 3-4 Total Orthopedic Biomaterials Market by Segment, U.S., 2014
- Chart 3-S Leading Competitors, Orthopedic Biomaterials Market, U.S., 2007
- Chart 3-6 Market Concentration, Orthopedic Biomaterials Market, U.S., 2007
- GROWTH FACTOR MARKET
- Chart 4-1 Total Growth Factor Market U.S. 2004-2014
- Chart 4-2 Leading Competitors, Growth Factor Market, U.S., 2007
- BONE GRAFT SUBSTITUTE MARKET
- Chart 5-1 Total Bone Graft Substitute Market U.S. 2004-2014
- Chart 5-2 Thoracolumbar Bone Graft Substitute Market U.S. 2004-2014
- Chart 5-3 Cervical Bone Graft Substitute Market U.S. 2004-2014
- Chart 5-4 Trauma Bone Graft Substitute Market, U.S., 2004-2014
- Chart 5-5 Hip Bone Graft Substitute Market, U.S., 2004-2014
- Chart 5-6 Knee Bone Graft Substitute Market, U.S., 2004-2014
- Chart 5-7 Craniomaxillofacial Bone Graft Substitute Market, U.S., 2004-2014
- Chart 5-8 Total Standard Allograft Market, U.S., 2004-2014
- Chart 5-9 Standard Spine Allograft Market, U.S., 2004-2014
- Chart 5-10 Thoracolumbar Standard Allograft Market, U.S., 2004-2014
- Chart 5-11 Cervical Standard Allograft Market, U.S., 2004-2014
- Chart 5-12 Extremity and CMF Standard Allograft Procedures, U.S., 2007
- Chart 5-13 Extremity and Craniomaxillofacial Standard Allograft Market,
U.S., 2004-2014
- Chart 5-14 Total DBM Market, U.S., 2004-2014
- Chart 5-15 Spinal DBM Market, U.S., 2004-2014
- Chart 5-16 Thoracolumbar DBM Market, U.S., 2004-2014
- Chart 5-17 Cervical DBM Market, U.S., 2004-2014
- Chart 5-18 Extremity and CMF DBM Procedures, U.S., 2007
- Chart 5-19 Extremity and Craniomaxillofacial DBM Market, U.S. 2004-2014
- Chart 5-20 Total Synthetic Bone Graft Substitute Market, U.S., 2004-2014
- Chart 5-21 Spinal Synthetic Bone Graft Substitute Market, U.S. 2007-2014
- Chart 5-22 Thoracolumbar Synthetic Bone Graft Substitute Market, U.S.,
2004-2014
- Chart 5-23 Cervical Synthetic Bone Graft Market . U.S. .2004-2014
- Chart 5-24 Extremity and CMF Synthetic Bone Graft Substitute Procedures,
U.S. 2007,
- Chart 5-25 Extremity and Craniomaxillofacial Synthetic Bone Graft
Substitute Market, U.S., 2004-2014
- Chart 5-26 Leading Competitors Bone Graft Substitutes Market, U.S. 2007
- Chart 5-27 Leading Competitors for Standard Allograft Market, U.S., 2007
- Chart 5-28 Leading Competitors for DBM Market, U.S., 2007
- Chart 5-29 Leading Competitors for Synthetic Bone Graft Substitutes, U.S.,
2007
- MACHINED BONE ALLOGRAFT MARKET
- Chart 6-1 Machined Allograft Market U.S. 2004-2014
- Chart 6-2 ALIF Machined Bone Allograft Market, U.S. .2004-2014
- Chart 6-3 PLIF Machined Bone Allograft Market, U.S., 2004-2014
- Chart 6-4 TLIF Machined Bone Allograft Market, U.S., 2004-2014
- Chart 6-5 Cervical Machined Bone Allograft Market, U.S., 2004-2014
- Chart 6-6 Leading Competitors, Machined Bone Allograft Market, U.S. 2007
- HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- Chart 7-1 Hyaluronic Acid Viscosupplementation Market, U.S., 2004-2014
- Chart 7-2 Three-Injection Cycle Viscosupplementation Market, U.S.,
2004-2014
- Chart 7-3 Five-Injection Cycle Hyluronic Acid Viscosupplmentation Market,
U.S. 2004-2014
- Chart 7-4 Leading Competitors, Hyaluronic Acid Viscosupplementation
Market, U.S., 2007
- RESORBABLE FIXATION DEVICES
- Chart 8-1 Total Resorbable Fixation Device Market, U.S., 2004-2014
- Chart 8-2 Total Resorbable Fixation Device Market by Segment, U.S.,
2004-2014
- Chart 8-3 Resorbable Shoulder Fixation Market, U.S., 200-2014
- Chart 8-4 Total ACL/PCL Resorbable Fixation Market, U.S. 2004-2014
- Chart 8-5 ACL/PCL Total Resorbable Interference Screw Market, U.S.,
2004-2014
- Chart 8-6 ACL/PCL Standard Resorbable Interference Screw Market, U.S.,
2004-2014
- Chart 8-7 ACL/PCL Composite Resorbable Interference Screw Market, U.S.,
2004-2014
- Chart 8-8 ACL/PCL Resorbable Cross Pin Market, U.S., 2004-2014
- Chart 8-9 Total Resorbable Meniscal Fixation Market, U.S., 2004-2014
- Chart 8-10 Meniscal Tack Market, U.S., 2004-2014
- Chart 8-11 Hybrid Tack Market, U.S., 2004-2014
- Chart 8-12 Resorbable Fracture Fixation Market, U.S., 2004-2014
- Chart 8-13 Leading Competitors, Total Resorbable Fixation Market, U.S.,
2007
- Chart 8-14 Leading Competitors, Resorbable Shoulder Fixation Market, U.S.
2007
- Chart 8-15 Leading Competitors, Resorbable ACL/PCL Fixation Market, U.S.
2007
- Chart 8-16 Leading Competitors, Resorbable Meniscus Fixation Market, U.S.,
2007
- Chart 8-17 Leading Competitors, Resorbable Fracture Fixation, U.S., 2007
- TENDON GRAFT MARKET
- Chart 9-1 Total Tendon Graft Market, U.S., 2004-2014
- Chart 9-2 Units Procured per Donor, U.S., 2007
- Chart 9-3 Leading Competitors, Tendon Graft Market, U.S., 2007
- CARTILAGE REPAIR MARKET
- Chart 10-1 Total Cartilage Repair Market, U.S., 2004-2014
- Chart 1O-2 ACI Market, U.S., 2004-2014
- Chart 10-3 Osteochondral Allograft Market, U.S., 2004-2014
- Chart 10-4 Meniscal Graft Market, U.S., 2004-2014
- Chart 1O-5 Leading Competitors, Total Cartilage Repair Market, U.S., 2007
- Chart 1O-6 Leading Competitors, ACI Market, U.S., 2007
- Chart 1O-7 Leading Competitors,Cartilage Allograft Market, U.S., 2007
- PLATELET AND BONE MARROW CONCENTRATION MARKET
- Chart 11-1 Total Platelet and Bone Marrow Concentration Market, U.S.,
2004-2014
- Chart 11-2 Spinal Platelet Concentration Market, U.S., 2004-2014
- Chart 11-3 Extremity and Sports Medicine Platelet Concentration, U.S.,
2004-2014
- Chart 11-4 Bone Marrow Aspirate Concentration, U.S., 2004-2104
- Chart 11-5 Leading Competitors, Platelet and Bone Marrow Concentration
Market, 2007
- 0RTHOPEDIC STEM CELL MARKET
- Chart 12-1 Orthopedic Stem Cell Market, U.S., 2004-2014
- Chart 12-2 Potential Stem Cell Market, 2008-2014
ABBREVIATIONS |
Related Report
|
View Cart
